Search clinical trials for: clindamycin phosphate 1.2%/tretinoin 0.025% gel alone

Total 71 results

Zeichner, Joshua, M.D.

Unknown

A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne

Acne Vulgaris

United States
Massachusetts General Hospital
Medicis Pharmaceutical Corporation

Completed

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

Rosacea

United States
Wake Forest University
Medicis Pharmaceutical Corporation

Completed

Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

Acne Vulgaris

United States
Callender Center for Clinical Research
Society Hill Dermatology

Unknown

Efficacy & Safety of Clindamycin and Tretinoin in Acne

Acne

United States
GlaxoSmithKline

Completed

W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers

Acne Vulgaris
Zeichner, Joshua, M.D.

Unknown

Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Acne Vulgaris | Acne

United States, Canada, Belize
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers

Acne Vulgaris
Watson Laboratories, Inc.

Completed

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Acne Vulgaris
Actavis Mid-Atlantic LLC

Completed

Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo

MILD TO SEVERE ACNE VULGARIS

India
Zydus Lifesciences Limited

Completed

To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

Acne Vulgaris

United States, India
Padagis LLC

Completed

A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris

Acne
Taro Pharmaceuticals USA

Completed

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Actavis Inc.

Completed

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Acne Vulgaris

United States
GWT-TUD GmbH

Completed

Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products (PREFECT)

Acne Vulgaris

Germany
Stiefel, a GSK Company
GlaxoSmithKline; Quintiles, Inc.; Rho, Inc.

Completed

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

Acne Vulgaris

United States, Canada, Belize
GlaxoSmithKline

Completed

A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris

Acne Vulgaris

China
Coria Laboratories, Ltd.

Completed

Clinical Evaluation of the Photoallergy Potential of Atralin Gel

Healthy

United States
Medicis Global Service Corporation

Completed

Combination Treatment for Moderate to Severe Acne

Acne

United States
Coria Laboratories, Ltd.

Completed

A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

Rosacea

United States
Coria Laboratories, Ltd.

Completed

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

Healthy

United States
Daré Bioscience, Inc.

Completed

DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)

Bacterial Vaginosis

United States
Eisai Limited

Completed

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Padagis LLC

Completed

Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris

Acne

United States
University of Southern California

Completed

Topical Treatment and Prevalence of P. Acnes

Surgical Site Infection

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Wake Forest University Health Sciences
Bausch Health Americas, Inc.

Not yet recruiting

Experience With Topical Acne Treatment

Acne

United States
Akorn, Inc.

Completed

Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Taro Pharmaceuticals USA

Completed

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Allergan

Completed

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

Acne Vulgaris

United States
Padagis LLC

Completed

Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne

Acne Vulgaris

United States
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

Acne Vulgaris

United States, Belize
Taro Pharmaceuticals USA

Completed

A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Lee's Pharmaceutical Limited
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

China
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

Acne Vulgaris
All India Institute of Medical Sciences, Bhubaneswar

Completed

Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris

Acne Vulgaris

India
Sanofi

Completed

A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.

Acne Vulgaris
Galderma R&D

Completed

Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

Photoaging

United States
Galderma R&D

Completed

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris (C0000-411)

Acne Vulgaris
Odense University Hospital

Unknown

Peritonsillar Abscess: Aspiration Versus Tonsillectomy a Chaud

Peritonsillar Abscess

Denmark
Jinnah Postgraduate Medical Centre

Completed

Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris

Acne Vulgaris

Pakistan
Allergan

Completed

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Acne Vulgaris

United States
Henry Ford Health System

Completed

Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States

3

Subscribe